
AdaptHealth Corp. Partners With a Major National Healthcare System to Become the Exclusive Provider of Home Medical Equipment
'We are excited to work with our new partner to help its members achieve their best health at home,' said AdaptHealth CEO Suzanne Foster. 'We were able to demonstrate how our combination of talent, expertise, and tech-enabled patient experience aligned with the healthcare system's innovative approach to serving its membership.'
Ms. Foster continued, 'This partnership reaffirms that we are uniquely positioned to drive non-acquired growth as we transform healthcare services in the home, through innovative service arrangements that deliver consistent experiences and more predictable costs to the patients, plan members, providers, and payors in the U.S. healthcare system.'
The agreement covers the national healthcare system's Medicare Advantage, Medicaid Managed Care, and privately insured patients.
About AdaptHealth Corp.
AdaptHealth is a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services. The Company operates under four reportable segments that align with its product categories: (i) Sleep Health, (ii) Respiratory Health, (iii) Diabetes Health, and (iv) Wellness at Home. The Sleep Health segment provides sleep therapy equipment, supplies and related services (including CPAP and BiLevel services) to individuals for the treatment of obstructive sleep apnea. The Respiratory Health segment provides oxygen and home mechanical ventilation equipment and supplies and related chronic therapy services to individuals for the treatment of respiratory diseases, such as chronic obstructive pulmonary disease and chronic respiratory failure. The Diabetes Health segment provides medical devices, including continuous glucose monitors and insulin pumps, and related services to patients for the treatment of diabetes. The Wellness at Home segment provides home medical equipment and services to patients in their homes including those who have been discharged from acute care and other facilities. The segment tailors a service model to patients who are adjusting to new lifestyles or navigating complex disease states by providing essential medical supplies and durable medical equipment.
The Company is proud to partner with an extensive and highly diversified network of referral sources, including acute care hospitals, sleep labs, pulmonologists, skilled nursing facilities, and clinics. AdaptHealth services beneficiaries of Medicare, Medicaid, and commercial insurance payors, reaching approximately 4.2 million patients annually in all 50 states through its network of approximately 630 locations in 47 states.
Forward Looking Statements
This press release includes certain statements that are not historical facts but are forward-looking statements for purposes of the safe harbor provisions under the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements generally are accompanied by words such as 'believe,' 'may,' 'will,' 'estimate,' 'continue,' 'anticipate,' 'intend,' 'expect,' 'should,' 'would,' 'plan,' 'predict,' 'potential,' 'seem,' 'seek,' 'future,' 'outlook,' and similar expressions that predict or indicate future events or trends or that are not statements of historical matters. These forward-looking statements are provided for illustrative purposes only and are not intended to serve as, and must not be relied on, by any investor as, a guarantee, an assurance, a prediction or a definitive statement of fact or probability. Actual events and circumstances are difficult or impossible to predict and will differ from assumptions. Many actual events and circumstances are beyond the control of the Company.
These forward-looking statements are subject to a number of risks and uncertainties, including the outcome of judicial and administrative proceedings to which the Company may become a party or governmental investigations to which the Company may become subject that could interrupt or limit the Company's operations, result in adverse judgments, settlements or fines and create negative publicity; changes in the Company's customers' preferences, prospects and the competitive conditions prevailing in the healthcare sector. A further description of such risks and uncertainties can be found in the Company's filings with the Securities and Exchange Commission. If the risks materialize or assumptions prove incorrect, actual results could differ materially from the results implied by these forward-looking statements. There may be additional risks that the Company presently knows or that the Company currently believes are immaterial that could also cause actual results to differ from those contained in the forward-looking statements. In addition, forward-looking statements reflect the Company's expectations, plans or forecasts of future events and views as of the date of this press release. The Company anticipates that subsequent events and developments will cause the Company's assessments to change. However, while the Company may elect to update these forward-looking statements at some point in the future, the Company specifically disclaims any obligation to do so. These forward-looking statements should not be relied upon as representing the Company's assessments as of any date subsequent to the date of this press release. Accordingly, undue reliance should not be placed on these forward-looking statements.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
a minute ago
- Yahoo
Stock market today: Dow, S&P 500, Nasdaq futures climb as Fed rate cut bets surge after inflation data
US stock futures climbed on Wednesday amid increasing expectations that the Federal Reserve will cut interest rates at its next meeting, following the latest inflation data. Futures attached to the Dow Jones Industrial Average (YM=F), the benchmark S&P 500 (ES=F), and the tech-heavy Nasdaq 100 (NQ=F) edged up 0.1%. In day trading, stocks roared after the release of the July CPI report, with the S&P 500 and Nasdaq both touching new records. Though the data showed inflation had ticked up, it increased by less than expected. The results boosted bets the Fed would cut interest rates at its September policy meeting, especially in light of recent warnings signs the labor market is weakening. In after-hours trading, Circle (CRCL) sank after the company announced it would sell 10 million shares on the heels of its first earnings report since its explosive public debut. Cava (CAVA) shares also dove after the company issued its first annual sales growth target cut. CoreWeave (CRWV) saw losses too despite beating revenue estimates on strong demand for AI. Later this week, investors will get two more snapshots on the state of the economy with the release of the Producer Price Index on Thursday and retail sales data on Friday. Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data

Wall Street Journal
4 minutes ago
- Wall Street Journal
Heard on the Street Tuesday Recap: Is a Rate Cut Coming?
Inflation remained steady in July, even as tariff increases began to show up more clearly. Consumer prices rose 2.7% in July from a year earlier, unchanged from June's gain. That was below the 2.8% rise expected by economists and keeps an interest-rate cut firmly on the table for September. Stocks advanced, with the Nasdaq Composite and the S&P 500 setting records. The Nasdaq added 1.4% and the S&P and Dow industrials both gained 1.1%. Treasury yields were mostly higher. The 10-year yield neared 4.3%. Intel shares rallied after President Trump said he had met with the chip maker's CEO. The president said Monday's meeting, also attended by Commerce Secretary Howard Lutnick and Treasury Secretary Scott Bessent, was 'very interesting.' Intel shares rose 5.6%.
Yahoo
6 minutes ago
- Yahoo
1 Cash-Heavy Stock on Our Buy List and 2 We Ignore
Companies with more cash than debt can be financially resilient, but that doesn't mean they're all strong investments. Some lack leverage because they struggle to grow or generate consistent profits, making them unattractive borrowers. Not all businesses with cash are winners, and that's why we built StockStory - to help you separate the good from the bad. Keeping that in mind, here is one company with a net cash position that balances growth with stability and two with hidden risks. Two Stocks to Sell: Zoom (ZM) Net Cash Position: $7.76 billion (36.6% of Market Cap) Started by Eric Yuan who once ran engineering for Cisco's video conferencing business, Zoom (NASDAQ:ZM) offers an easy to use, cloud-based platform for video conferencing, audio conferencing and screen sharing. Why Are We Cautious About ZM? Products, pricing, or go-to-market strategy may need some adjustments as its 5% average billings growth over the last year was weak Platform has low switching costs as its net revenue retention rate of 98% demonstrates high turnover Projected sales growth of 3% for the next 12 months suggests sluggish demand At $70.50 per share, Zoom trades at 4.5x forward price-to-sales. To fully understand why you should be careful with ZM, check out our full research report (it's free). Stitch Fix (SFIX) Net Cash Position: $135 million (21.4% of Market Cap) One of the original subscription box companies, Stitch Fix (NASDAQ:SFIX) is an online personal styling and fashion service that curates personalized clothing selections for customers. Why Do We Think SFIX Will Underperform? Demand for its offerings was relatively low as its number of active clients has underwhelmed Poor expense management has led to operating margin losses Eroding returns on capital from an already low base indicate that management's recent investments are destroying value Stitch Fix's stock price of $4.84 implies a valuation ratio of 13.5x forward EV-to-EBITDA. If you're considering SFIX for your portfolio, see our FREE research report to learn more. One Stock to Buy: Powell (POWL) Net Cash Position: $432.4 million (13.3% of Market Cap) Originally a metal-working shop supporting local petrochemical facilities, Powell (NYSE:POWL) has grown from a small Houston manufacturer to a global provider of electrical systems. Why Is POWL a Good Business? Annual revenue growth of 28.7% over the past two years was outstanding, reflecting market share gains this cycle Incremental sales significantly boosted profitability as its annual earnings per share growth of 124% over the last two years outstripped its revenue performance Free cash flow margin grew by 12.8 percentage points over the last five years, giving the company more chips to play with Powell is trading at $270.15 per share, or 18.4x forward P/E. Is now a good time to buy? See for yourself in our full research report, it's free. High-Quality Stocks for All Market Conditions When Trump unveiled his aggressive tariff plan in April 2025, markets tanked as investors feared a full-blown trade war. But those who panicked and sold missed the subsequent rebound that's already erased most losses. Don't let fear keep you from great opportunities and take a look at Top 9 Market-Beating Stocks. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025). Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+351% five-year return). Find your next big winner with StockStory today for free. Find your next big winner with StockStory today. Find your next big winner with StockStory today StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data